Cellebrite DI (NASDAQ:CLBT) Hits New 52-Week High – What’s Next?

Cellebrite DI Ltd. (NASDAQ:CLBT) shares reached a new 52-week high on Tuesday . The company traded as high as $18.96 and last traded at $18.96, with a volume of 1545 shares traded. The stock had previously closed at $18.06.

Analyst Ratings Changes

A number of brokerages have recently issued reports on CLBT. TD Cowen increased their price objective on shares of Cellebrite DI from $20.00 to $23.00 and gave the stock a “buy” rating in a research note on Monday, September 23rd. Lake Street Capital increased their price target on Cellebrite DI from $13.50 to $17.00 and gave the stock a “buy” rating in a research note on Friday, August 16th. Needham & Company LLC boosted their price objective on Cellebrite DI from $14.00 to $17.00 and gave the company a “buy” rating in a research report on Friday, August 16th. Craig Hallum increased their target price on Cellebrite DI from $20.00 to $23.00 and gave the stock a “buy” rating in a research report on Wednesday, September 25th. Finally, Bank of America boosted their price target on Cellebrite DI from $13.00 to $17.00 and gave the stock a “buy” rating in a report on Friday, August 16th. Eight analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $18.57.

Cellebrite DI Stock Up 0.4 %

The business has a 50 day moving average of $16.72 and a 200 day moving average of $13.41. The company has a market capitalization of $3.74 billion, a P/E ratio of -34.26, a price-to-earnings-growth ratio of 2.48 and a beta of 1.52.

Cellebrite DI (NASDAQ:CLBT) last posted its earnings results on Thursday, August 15th. The company reported $0.10 EPS for the quarter, beating analysts’ consensus estimates of $0.08 by $0.02. Cellebrite DI had a positive return on equity of 5,902.06% and a negative net margin of 28.51%. The firm had revenue of $95.70 million during the quarter, compared to the consensus estimate of $91.94 million. During the same period in the prior year, the company earned $0.05 EPS. The company’s quarterly revenue was up 24.8% compared to the same quarter last year. On average, research analysts anticipate that Cellebrite DI Ltd. will post 0.31 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Point72 Asia Singapore Pte. Ltd. raised its position in Cellebrite DI by 59.6% during the second quarter. Point72 Asia Singapore Pte. Ltd. now owns 2,724 shares of the company’s stock valued at $33,000 after purchasing an additional 1,017 shares during the period. Public Employees Retirement Association of Colorado purchased a new stake in Cellebrite DI during the 2nd quarter valued at $71,000. nVerses Capital LLC bought a new stake in Cellebrite DI in the second quarter worth $103,000. TD Asset Management Inc purchased a new position in Cellebrite DI during the second quarter worth $121,000. Finally, Magnetar Financial LLC bought a new position in Cellebrite DI during the second quarter valued at $143,000. Institutional investors own 45.88% of the company’s stock.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.